[go: up one dir, main page]

GB202013571D0 - Injectable formulation - Google Patents

Injectable formulation

Info

Publication number
GB202013571D0
GB202013571D0 GBGB2013571.1A GB202013571A GB202013571D0 GB 202013571 D0 GB202013571 D0 GB 202013571D0 GB 202013571 A GB202013571 A GB 202013571A GB 202013571 D0 GB202013571 D0 GB 202013571D0
Authority
GB
United Kingdom
Prior art keywords
injectable formulation
injectable
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2013571.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Small Pharma Ltd
Original Assignee
Small Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Small Pharma Ltd filed Critical Small Pharma Ltd
Priority to GBGB2013571.1A priority Critical patent/GB202013571D0/en
Publication of GB202013571D0 publication Critical patent/GB202013571D0/en
Priority to MX2022014128A priority patent/MX2022014128A/en
Priority to KR1020227042030A priority patent/KR102636385B1/en
Priority to AU2021334933A priority patent/AU2021334933B2/en
Priority to CA3179335A priority patent/CA3179335C/en
Priority to HUE21769080A priority patent/HUE068716T2/en
Priority to PCT/EP2021/073189 priority patent/WO2022043227A1/en
Priority to ES21769080T priority patent/ES2988546T3/en
Priority to BR112022022198-3A priority patent/BR112022022198B1/en
Priority to HRP20241337TT priority patent/HRP20241337T1/en
Priority to IL298129A priority patent/IL298129B2/en
Priority to PL21769080.9T priority patent/PL4138818T3/en
Priority to JP2022577123A priority patent/JP7422474B2/en
Priority to EP21769080.9A priority patent/EP4138818B1/en
Priority to CN202180044031.5A priority patent/CN115701994B/en
Priority to NZ793361A priority patent/NZ793361B2/en
Priority to EP24194778.7A priority patent/EP4438034A3/en
Priority to US17/459,284 priority patent/US11406619B2/en
Priority to US17/806,526 priority patent/US12343327B2/en
Priority to ZA2023/01086A priority patent/ZA202301086B/en
Priority to US19/202,059 priority patent/US20250262187A1/en
Ceased legal-status Critical Current

Links

GBGB2013571.1A 2020-08-28 2020-08-28 Injectable formulation Ceased GB202013571D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GBGB2013571.1A GB202013571D0 (en) 2020-08-28 2020-08-28 Injectable formulation
EP24194778.7A EP4438034A3 (en) 2020-08-28 2021-08-20 Injectable formulation
IL298129A IL298129B2 (en) 2020-08-28 2021-08-20 Injectable formulation comprising the fumarate salt of dimethyltryptamine or deuterated dimethyltryptamine
JP2022577123A JP7422474B2 (en) 2020-08-28 2021-08-20 Injectable preparations
AU2021334933A AU2021334933B2 (en) 2020-08-28 2021-08-20 Injectable formulation
CA3179335A CA3179335C (en) 2020-08-28 2021-08-20 Injectable formulation
HUE21769080A HUE068716T2 (en) 2020-08-28 2021-08-20 Injectable formulation
PCT/EP2021/073189 WO2022043227A1 (en) 2020-08-28 2021-08-20 Injectable formulation
ES21769080T ES2988546T3 (en) 2020-08-28 2021-08-20 Injectable formulation
BR112022022198-3A BR112022022198B1 (en) 2020-08-28 2021-08-20 INJECTABLE FORMULATION
HRP20241337TT HRP20241337T1 (en) 2020-08-28 2021-08-20 Injectable formulation
MX2022014128A MX2022014128A (en) 2020-08-28 2021-08-20 Injectable formulation.
PL21769080.9T PL4138818T3 (en) 2020-08-28 2021-08-20 Injectable formulation
KR1020227042030A KR102636385B1 (en) 2020-08-28 2021-08-20 Injectable preparation
EP21769080.9A EP4138818B1 (en) 2020-08-28 2021-08-20 Injectable formulation
CN202180044031.5A CN115701994B (en) 2020-08-28 2021-08-20 Injectable formulations
NZ793361A NZ793361B2 (en) 2021-08-20 Injectable formulation
US17/459,284 US11406619B2 (en) 2020-08-28 2021-08-27 Injectable formulations
US17/806,526 US12343327B2 (en) 2020-08-28 2022-06-13 Injectable formulations
ZA2023/01086A ZA202301086B (en) 2020-08-28 2023-01-25 Injectable formulation
US19/202,059 US20250262187A1 (en) 2020-08-28 2025-05-08 Injectable formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2013571.1A GB202013571D0 (en) 2020-08-28 2020-08-28 Injectable formulation

Publications (1)

Publication Number Publication Date
GB202013571D0 true GB202013571D0 (en) 2020-10-14

Family

ID=72749770

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2013571.1A Ceased GB202013571D0 (en) 2020-08-28 2020-08-28 Injectable formulation

Country Status (1)

Country Link
GB (1) GB202013571D0 (en)

Similar Documents

Publication Publication Date Title
HUE068716T2 (en) Injectable formulation
EP3890732A4 (en) Injectable formulations
IL287628A (en) Injectable pharmaceutical compositions and uses thereof
IL277802A (en) Injectable composition
GB202007546D0 (en) Formulation
GB202113944D0 (en) Injectable formulations
IL307849A (en) Sotorasib formulation
GB202013571D0 (en) Injectable formulation
GB202102636D0 (en) Formulation
HK40115195A (en) Injectable formulation
HK40116527A (en) New injectable combination formulation
IL308046A (en) Alpelisib formulation
ZA202102140B (en) Sustained-release injectable antibiotical formulation
GB202108165D0 (en) Formulation
GB202107439D0 (en) Formulation
GB202107203D0 (en) Formulation
PL4138585T3 (en) Aerosolisable formulation
ZA202105883B (en) Ready-to-use injectable formulations
GB202103970D0 (en) Formulation
GB202102408D0 (en) Formulation
GB202016274D0 (en) Formulation
GB202010573D0 (en) Formulation
GB2599912B (en) New formulation
HUP2100259A1 (en) Controlled release injectable cariprazine formulation
GB202005340D0 (en) Formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)